Skip to main content
VCbacked
Log inGet Started

XyloCor Therapeutics

King Of Prussia, United States

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

$67.5M raised
Jan 2025
Series B
BiotechnologyHealth CarePharmaceutical

Top Investors

Jeito CapitalEQT Life SciencesLongwood FundLumira VenturesSofinnova Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about XyloCor Therapeutics

How much funding has XyloCor Therapeutics raised?
XyloCor Therapeutics has raised $67.5M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Who are XyloCor Therapeutics's investors?
XyloCor Therapeutics's investors include Jeito Capital, EQT Life Sciences, Longwood Fund, Lumira Ventures, Sofinnova Investments.
Where is XyloCor Therapeutics headquartered?
XyloCor Therapeutics is headquartered in King Of Prussia, United States.
What does XyloCor Therapeutics do?
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
What stage is XyloCor Therapeutics at?
XyloCor Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"XyloCor Therapeutics — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/xylocor-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2025). XyloCor Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/xylocor-therapeutics
Wikipedia (cite web)
{{cite web |title=XyloCor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xylocor-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong